Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Managing disease

This page shows the latest Managing disease news and features for those working in and with pharma, biotech and healthcare.

NICE says no to AZ and Vifor’s rival hyperkalaemia drugs

NICE says no to AZ and Vifor’s rival hyperkalaemia drugs

Most common in patients with poor kidney function, heart failure or liver disease, hyperkalemia can be fatal, and patients have had few options for treatment until now. ... The companies argue that this exposes patients to cardiovascular disease risk,

Latest news

  • Roche wins CHMP backing for Hemlibra Roche wins CHMP backing for Hemlibra

    disease burden of managing the disease. ... The CHMP’s recommendation is based on the results of two phase III clinical studies for people with this particular disease indication.

  • Sanofi looks to mobile data to power behavioural analysis Sanofi looks to mobile data to power behavioural analysis

    The three-year partnership aims to increase Sanofi’s understanding of disease burden and develop solutions from the data that will improve therapeutic outcomes. ... We can then use those insights to support patients and healthcare professionals in

  • Forming a picture of health Forming a picture of health

    only likely to contribute to chronic disease in later life, but are already causing health problems among children. ... Managing diseases. One such manageable chronic disease is HIV, thanks to a decade of progress that has seen it transformed from a

  • Takeda and Marvel extend IBD cartoon initiative Takeda and Marvel extend IBD cartoon initiative

    Takeda Pharmaceuticals has launched the next part of its cartoon-based disease awareness partnership with Marvel. ... s disease and Luminaria, a nurse from Singapore that can soothe her IBD patients with her superhuman powers.

  • Top three therapeutic areas lead pharma’s pipeline Top three therapeutic areas lead pharma’s pipeline

    Almost 7, 000 new cancer products are in the works, nearly double the respective totals of CNS and infectious disease products currently lined up. ... Managing analyst for GBI Research Dominic Trewartha said this industry-wide trend is due to the

More from news
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • The patient’s world is ‘messy’ The patient’s world is ‘messy’

    The patient world is multidimensional and what may seem irrelevant, clinically, may be crucial to managing and treating a disease optimally. ... The emotional and social impact of the disease is left out in order to try and speak the HCP’s

  • The EarthWorks: New ways to improve patient care The EarthWorks: New ways to improve patient care

    Keeping people well and preventing illness. Technology is only interesting socially when it is boring technologically; we have to have scale to begin to prevent disease on a population level. ... Managing disease and improving patient outcomes. We can

  • The logistics of orphan drugs The logistics of orphan drugs

    Managing a rare disease global access programme, the goal is to minimise risk and get the drug to the patient on time. ... When managing logistics for a global access programme, the goal must be to minimise risk and get the drug to the patient on time.

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Cidara Therapeutics makes senior appointments Cidara Therapeutics makes senior appointments

    He also joins from Merck, where he has served as senior scientific director and team leader, managing programmes in areas including infectious disease, metabolic syndrome and thrombosis disease.

  • New medical communications head for S&H New medical communications head for S&H

    In her new role at S&H Pearson will be responsible for managing its medical communications team and driving its growth in the sector. ... Prior to joining the industry Pearson was in academic research, obtaining a DPhil from the University of Oxford

  • GCI Health backs growth with new talent GCI Health backs growth with new talent

    Goldberg joins from Ruder Finn, where she was a senior vice president, managing global clients across multiple disease areas.

  • Kane & Finkel announces new European director

    In addition, as director of communications for the UK's Health Education Authority, he also developed public health campaigns for AIDS, smoking cessation, childhood immunisation and heart disease. ... John Kane, principal and managing director of Kane

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Quick links

Infographics

Multimedia